网络出版日期: 2016-12-18
基金资助
国家自然科学基金项目(81501390)资助
Diagnostic significance of anti-collectin 11 in systemic lupus erythematosus
Online published: 2016-12-18
Supported by
Supported by the National Natural Science Foundation of China (81501390)
目的:评价抗collectin 11抗体在系统性红斑狼疮(systemic lupus erythematosus, SLE)的诊断和病情活动性判断中的作用。方法: 本研究为横断面研究,同时纳入SLE活动组、SLE缓解组、类风湿关节炎(rheumatoid arthritis,RA)组、原发性干燥综合征(Sj-gren syndrome,SS)组以及健康对照(healthy control,HC)组5组患者,应用ELISA方法检测血清抗collectin 11抗体水平,比较各组差异并进行受试者工作特征(receiver operating characteristic,ROC)曲线分析。结果: 5组各纳入30例患者,SLE活动组和SLE缓解组之间抗collectin 11抗体水平差异无统计学意义(88.8±16.8 vs. 89.7±24.7,P=0.896)。SLE组作为一个整体,其抗collectin 11抗体水平(89.1±19.4)显著高于RA组(49.1±22.0)、SS组(56.9±30.1)以及HC组(72.7±24.6)(P<0.001,P<0.001,P=0.007)。抗collectin 11抗体诊断SLE的ROC曲线下面积为0.806,提示具有一定的诊断价值,并且与其他SLE特异性自身抗体有一定的互补作用。结论: 血清抗collectin 11抗体在SLE组中显著高于RA组、SS组以及HC组,并具有一定的诊断价值,有可能成为SLE新的特异性自身抗体之一。
邓晓莉 , 钟丽君 , 孙琳 , 李常虹 , 刘湘源 . 抗collectin 11抗体在系统性红斑狼疮诊断中的意义[J]. 北京大学学报(医学版), 2016 , 48(6) : 982 -986 . DOI: 10.3969/j.issn.1671-167X.2016.06.011
Objective: To analyze the role of anti-collectin 11 in the diagnosis of systemic lupus erythematosus (SLE) and in the evaluation of disease activity. Methods: This was a cross-sectional study. Five groups of patients were enrolled: SLE active (SLE disease activity index-2000,SLEDAI-2000≥9), SLE remission (SLEDAI-2000≤4 and there was no organ involvement), rheumatoid arthritis (RA), primary Sj-gren Syndrome (SS) and healthy control (HC). Serum anticollectin 11 was detected in all the groups by ELISA. One-way ANOVA analysis and LSD-t test as post-hoc analysis were used to compare the levels of anticollectin 11 among all the groups. Receiver operating characteristic (ROC) curve and the area under curve (AUC) were used to analyze the value of anticollectin 11 in the diagnosis of SLE. Results: In the study, 30 patients were enrolled in each group, including 13 males and 137 females with an average age of (34±14) years (18-77 years). The age and gender of the other three groups were comparable to the two SLE groups. The difference of serum anti-collectin 11 between the SLE active group and SLE remission group was not statistically significant (88.8±16.8 vs. 89.7±24.7, P=0.896). The level of serum anti-collectin 11 was significantly higher in SLE group (as a whole) (89.1±19.4) than in RA group (49.1±22.0), SS group (56.9±30.1) and HC group (72.7±24.6) (P<0.001, P<0.001, P=0.007, respectively). The AUC was 0.806 for the diagnosis of SLE by serum anti-collectin 11. Further descriptive analysis showed that the positive rate of anti-collectin 11 was very high in the patients of SLE in whom both anti-double-stranded DNA (dsDNA) and Sm antibody were negative. The nervous system and gastrointestinal system involvement were the most common in the patients with positive anti-collectin 11. Conclusion: The level of serum anti-collectin 11 was significantly higher in SLE than in RA, SS and HC. Anti-collectin 11 antibody had a relatively high value in the diagnosis of SLE and it might have some complementary function in the diagnosis of SLE. It might be a relatively specific autoantibody for SLE.
Key words: Lupus erythematosus, systemic; Collectins; Diagnosis
/
| 〈 |
|
〉 |